Coronavirus (COVID-19) Update: FDA updates on surveillance inspections during COVID-19
For Immediate Release: May 11, 2020 Statement From: Commissioner of Food and Drugs – Food and Drug Administran Stephen M. Hahn M.D. During COVID-19, the U.S. Food and Drug Administration will continue to utilize and implement additional alternative inspection tools and approaches while postponing domestic and foreign routine surveillance inspections. This will continue as local, […]